Genetic Association Reveals Protection against Recurrence of <i>Clostridium difficile</i> Infection with Bezlotoxumab Treatment.

mSphere · 2020 · PMC7203456 · PMID 32376702

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

Participants carrying the rs2516513 T allele or the HLA-DRB1*07:01 allele exhibited a strong trend for benefit of bezlotoxumab treatment in the high-risk rCDI category.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.